Abstract Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and
social impact for which multiple conventional and novel pharmacotherapies are currently …

Obesity is one of the main risk factors for type 2 diabetes (T2D), representing a major
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

ABSTRACT The American Association of Clinical Endocrinologists/American College of
Endocrinology Medical Guidelines for Clinical Practice are systematically developed …

AACE Task Force for Developing a Diabetes Comprehensive Care Plan Writing Committee
Complete guidelines are available at www. aace. com These are clinical practice guidelines …

The current classification system presents challenges to the diagnosis and treatment of
patients with diabetes mellitus (DM), in part due to its conflicting and confounding definitions …

Abstract Purpose of Review This narrative review appraises research data on the potentially
harmful effect of obesity and insulin resistance (IR) co-existence with type 1 diabetes …

Aim To compare the safety, pharmacokinetics and pharmacodynamics of ADO09 with insulin
lispro (Lispro) and separate subcutaneous injections of human insulin and pramlintide …

Amylin, a peptide hormone produced in the pancreas and in the brain, has well-established
physiological roles in glycemic regulation and energy balance control. It improves …

There is considerable benefit of tight glucose control in patients with type 1 diabetes
mellitus. Tight blood glucose control dramatically decreases the incidence of microvascular …